REGENOSINE INC
Treatment and prevention of osteoarthritis with an intra-articular disease-modifying regenerative therapy
Based based in Princeton, NJ, REGENOSINE INC works in national institute of arthritis and musculoskeletal and skin diseases.
Profile
Regenosine is developing a first-in-class disease-modifying regenerative therapy for osteoarthritis. Its injectable slow-release adenosine formulation regenerates the articular cartilage and potentially delays the need for joint replacement procedures.
REGENOSINE INC is positioned in national institute of arthritis and musculoskeletal and skin diseases, a segment that rewards a clear, focused offering.
Princeton, NJ is where the company is located.
It is recorded at the SBIR/STTR stage.
Public records show total funding of about $399K.
| Sector | National Institute of Arthritis and Musculoskeletal and Skin Diseases |
|---|---|
| Headquarters | Princeton, NJ |
| Country | UNITED STATES |
| Stage | SBIR/STTR |
| Total funding | $399,378 |
Website: regenosine.com
Browse related
Create a free account